The REPAIR Study: Effects of Macitentan on RV Structure and Function in Pulmonary Arterial Hypertension

New Research Paper

Anton Vonk Noordegraaf et al.

J Am Coll Cardiol Img. Nov 17, 2021. Epublished DOI: 10.1016/j.jcmg.2021.07.027

Objectives:

The REPAIR (Right ventricular remodeling in Pulmonary Arterial hypertension) study evaluated the effect of macitentan on right ventricular (RV) and hemodynamic outcomes in patients with pulmonary arterial hypertension (PAH), using cardiac magnetic resonance (CMR) and right heart catheterization (RHC).

For further information regarding Opsumit® (macitentan) or Uptravi® (Selexipag) including indication and adverse effects please refer to the Israeli MOH prescribing information: https://israeldrugs.health.gov.il/#!/byDrug

CP-287199 - April 2022
J-C Health Care Ltd. – Janssen Israel, Kibbutz Sheffayim 6099000, fax 09-9583636 info-janssen@its.jnj.com
OneTrust Privacy Policyמידע משפטי
Logo